Allarity Therapeutics (ALLR) Preferred Shares (2022 - 2024)

Allarity Therapeutics' (ALLR) quarterly Preferred Shares came in at $1.5 million in Q1 2024, down 13.32% on a QoQ basis from $1.7 million in Q4 2023.

Allarity Therapeutics (ALLR) Preferred Shares (2022 - 2024) Analysis & Trends

Allarity Therapeutics (ALLR) has 3 years of Preferred Shares data on file, last reported at $1.5 million in Q1 2024.

Quarterly Preferred Shares changed N/A year-over-year to $1.5 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $1.5 million (changed N/A YoY) and the FY2023 annual result came in at $1.7 million, up 87000.0% from the prior year.
Preferred Shares retreated to $1.5 million in Q1 2024, from $1.7 million in the prior quarter.
In the past five years, Preferred Shares ranged from a high of $5.6 million in Q2 2023 to a low of $2000.0 in Q4 2022.
A 3-year average of $2.1 million and a median of $1.7 million in 2023 frame the typical range for Preferred Shares.
The widest YoY moves for Preferred Shares: up 87000.0% in 2023, down 87000.0% in 2023.
Tracing ALLR's Preferred Shares over 3 years: stood at $2000.0 in 2022, then soared by 87000.0% to $1.7 million in 2023, then decreased by 13.32% to $1.5 million in 2024.
The last three Preferred Shares figures came in at $1.5 million (Q1 2024), $1.7 million (Q4 2023), and $1.7 million (Q3 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Allarity Therapeutics	22.75 Mn	22.75 Mn	-	-

Download Data